[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351447-105":59,"doc-detail-351447-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","n-lodds-a-novel-integrated-lymph-node-staging-system-enhancing-prognostic-accuracy-in-non-small-cell-lung-cancer","N‑LODDS: A Novel Integrated Lymph Node Staging System Enhancing Prognostic Accuracy in Non‑Small‑Cell Lung Cancer","","This study develops and validates N‑LODDS, a novel lymph node staging system that integrates anatomical location with quantitative lymph node characteristics, aiming to improve prognostic prediction in non‑small‑cell lung cancer (NSCLC) and to establish a multivariate prognostic model. Using 23,676 NSCLC patients from the SEER database (2010–2015), optimal cutoffs for lymph node parameters (NPLN, LNR, LODDS) were obtained with X‑tile. Cox regression identified independent prognostic factors and a nomogram was constructed. Predictive performance was evaluated with ROC curves, calibration plots, and decision curve analysis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/n-lodds-a-novel-integrated-lymph-node-staging-system-enhancing-prognostic-accuracy-in-non-small-cell-lung-cancer/351447/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/n-lodds-a-novel-integrated-lymph-node-staging-system-enhancing-prognostic-accuracy-in-non-small-cell-lung-cancer/351447.png","ImageObject",300,407,{"name":92,"@type":93},"Taylor Morgan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does the N‑LODDS lymph node staging system integrate?","Question",{"text":112,"@type":113},"N‑LODDS integrates anatomical lymph node location with quantitative lymph node features to improve prognostic accuracy in NSCLC.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the N‑LODDS system developed and validated?",{"text":117,"@type":113},"The study used 23,676 NSCLC patients from the SEER database (2010–2015) and determined optimal parameter cutoffs with X‑tile, then built a Cox regression-based nomogram and assessed performance with ROC, calibration, and decision curve analyses in training and validation cohorts.",{"name":119,"@type":110,"acceptedAnswer":120},"How does N‑LODDS perform compared with existing N‑staging approaches?",{"text":121,"@type":113},"N‑LODDS staging demonstrated optimal prognostic prediction and significantly outperformed N‑LNR and N‑NPLN, with the nomogram also showing advantages over the TNM staging system.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351447,1790153276,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099523885336,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Ann Surg Oncol (2026) 33:4242–4255  \n[https://doi.org/10.1245/s10434-025-19005-x](https://doi.org/10.1245/s10434-025-19005-x)  \nORIGINAL ARTICLE – THORACIC ONCOLOGY AND ESOPHAGEAL CANCER  \nN‑LODDS: A Novel Integrated Lymph Node Staging System Enhancing Prognostic Accuracy in Non‑Small‑Cell Lung Cancer  \nQiying Chen, BS1, Meihong Yao, MD2, Zishan Chen, MD3, Shiwen Liu, BS1, Jinman Zhuang, MD1,  \nXi Chen, BS1, Jie Yi, BS1, Binghua Tu, BS1, Ziyue Yang, BS1, Yinghong Yang, MBBS2, and Fei He, PhD1,4  \n1Department of Epidemiology and Health Statistics, The School of Public Health, Fujian Medical University, Fuzhou, Fujian, China; 2Department of Pathology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China; 3Maternal and Child Health Hospital of Fuzhou Second General Hospital, Fuzhou, Fujian, China; 4Fujian Digital Tumor Data Research Center, Fuzhou, Fujian, China  \nABSTRACT  \nBackground. This study aimed to develop and validate a novel lymph node staging system integrating anatomical location and quantitative characteristics, evaluate its prognostic prediction efficacy in non-small-cell lung cancer (NSCLC), and establish a multivariate prognostic model. Methods. A total of 23,676 patients with NSCLC from the SEER database (2010–2015) were enrolled. Optimal cutoffs for lymph node parameters (NPLN, LNR, LODDS) were determined using X-tile software. Composite variables (N-NPLN, N-LNR, N-LODDS) were constructed by integrating N staging. Independent prognostic factors were screened via Cox regression, and a nomogram was developed. Performance was assessed using the receiver operating characteristic curves, calibration curves, and decision curve analysis.  \nResults. N-LODDS staging demonstrated optimal prognostic prediction, significantly outperforming N-LNR and N-NPLN. The nomogram incorporating N-LODDS, tumor size, and nine independent prognostic factors showed superior discrimination and calibration (5 year area under the  \nQiying Chen and Meihong Yao have contributed equally to this work and share first authorship.  \n© The Author(s) 2026  \nFirst Received: 30 July 2025  \nAccepted: 18 December 2025  \nPublished online: 20 January 2026  \nY. Yang, MBBS[e-mail: 1555yyh@fjmu.edu.cn](e-mail: 1555yyh@fjmu.edu.cn)  \n[F](F). He, PhD[e-mail: i.fei.he@fjmu.edu.cn](e-mail: i.fei.he@fjmu.edu.cn)  \ncurve 0 .740; 95% confidence interval 0 .731–0.749) in both training and validation cohorts, with significant advantages over the TNM staging system (all P\u003C0.001) .  \nConclusion. The N-LODDS staging system significantly improves prognostic accuracy by integrating anatomical and quantitative lymph node features, providing a novel tool for personalized NSCLC management. Future multicenter prospective studies are needed to validate its clinical utility.  \nKeywords Lymph node metastasis · Surveillance, Epidemiology, and End Results (SEER) · Non-small cell lung cancer (NSCLC) · Nomogram · Log odds of positivelymph nodes (LODDS)  \nIMPLICATIONS FOR PRACTICE  \nThe N-LODDS staging system integrates anatomical and quantitative lymph node features, offering superior prognostication for resected N0-N2 non-small-cell lung cancer. Its core clinical implications include that it can improves the detection of occult metastasis in N0 patients, guiding adjuvant therapy; the nomogram enables individualized survival prediction, outperforming TNM staging; and it mandates standardized lymph node dissection/quantification to prevent under-staging. Prospective validation is warranted, but this provides a practical postoperative management framework.  \nINTRODUCTION  \nAccording to the 2022 data released by the International Agency for Research on Cancer, global cancer-related deaths reached 9.7 million cases, and lung cancer fatalities accounted for nearly 2.5 million cases, representing one-eighth of all cancer mortality and ranking first among  \ncancer-related deaths.1 Non-small-cell lung cancer (NSCLC) accounts for 85% of all lung cancer cases.2 Lymph node metastasis","cbCaimVQpF60XuBF","https://ap.wps.com/l/cbCaimVQpF60XuBF","pdf",887919,14,"English","# Abstract\n# Implications for Practice\n# Introduction\n# Methods\n# Results\n# Conclusion","[{\"question\":\"What does the N‑LODDS lymph node staging system integrate?\",\"answer\":\"N‑LODDS integrates anatomical lymph node location with quantitative lymph node features to improve prognostic accuracy in NSCLC.\"},{\"question\":\"How was the N‑LODDS system developed and validated?\",\"answer\":\"The study used 23,676 NSCLC patients from the SEER database (2010–2015) and determined optimal parameter cutoffs with X‑tile, then built a Cox regression-based nomogram and assessed performance with ROC, calibration, and decision curve analyses in training and validation cohorts.\"},{\"question\":\"How does N‑LODDS perform compared with existing N‑staging approaches?\",\"answer\":\"N‑LODDS staging demonstrated optimal prognostic prediction and significantly outperformed N‑LNR and N‑NPLN, with the nomogram also showing advantages over the TNM staging system.\"}]","N‑LODDS: A Novel Integrated Lymph Node Staging System Enhancing Prognostic Accuracy in Non‑Small‑Cell Lung Cancer | PDF",1790094201,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ecac19efcb20328f680754e038e14fe.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b167393a23d42c9c5452aae6525420ef.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d80ca4956af3d31bb4def9d25602ae05.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/50b492d2f564f42aedd4e413cfbb0c60.webp",980,1301]